Treatment of hepatic encephalopathy: It's not lactulose

BMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7457.112 (Published 08 July 2004) Cite this as: BMJ 2004;329:112
  1. Debbie L Shawcross, research fellow (d.shawcross@ucl.ac.uk),
  2. Rajiv Jalan, senior lecturer
  1. Liver Failure Group, Institute of Hepatology, London WC1E 6HX

    EDITOR—Als-Nielsen et al systematically reviewed randomised trials using lactulose or lactilol for hepatic encephalopathy,1 which has been warranted for some time. We agree that non-absorbable disaccharides have been introduced into clinical practice without any convincing evidence base but …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription